{"id":"221614f8-e4a5-4445-a1b6-bbfd4f93ba3f","modelId":"b336d883-18f3-4e77-bb20-bd3e62757e78","versionId":null,"locationId":"ee320ac7-3d14-4a80-bd64-336f2e601f9d","operatorId":"af791bbb-c3b4-4628-bfe7-8404c754dd09","ownerId":null,"slug":"btemia-keeogo-canada-clinical","status":"operational","firstSeen":"2024-06-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["autonomous_operation"],"shiftStructure":null,"hoursPerDay":8,"siteType":"hospital","operatorConfirmed":false,"humanSupervisionOnsite":null,"locationPrecisionTier":"verified_coordinates","deploymentScale":"medium_11_100","siteEnvironment":"indoor","operatorType":"maker_operated","sourceQualityTier":2,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://b-temia.com/","title":"B-TEMIA","date_accessed":"2026-06-07"},{"url":"https://keeogo.com/about-keeogo/clinical-studies","title":"Keeogo Clinical Studies | BTemia","retrievedAt":"2026-06-27T12:00:00Z"},{"url":"https://b-temia.com/home/media-room/b-temias-keeogo-obtains-ce-marking-allowing-its-commercialization-in-eu-countries","title":"B-Temia's Keeogo Obtains CE Marking Allowing Its Commercialization in EU Countries","retrievedAt":"2026-06-27T12:00:00Z"}],"notes":"B-TEMIA Keeogo powered exoskeleton deployed at rehabilitation clinics in Montreal, Canada. FDA-cleared for stroke and MS patients.","keyFacts":[{"label":"Technology","value":"B-TEMIA Keeogo powered exoskeleton"},{"label":"Coverage","value":"Montreal, Canada"},{"label":"Use Case","value":"Rehabilitation clinics for stroke and MS patients"},{"label":"Regulatory","value":"FDA-cleared"}],"reviewNote":null,"exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"healthcare","scaleTier":"commercial_10_99","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-06-07T22:54:24.627Z","updatedAt":"2026-08-21T14:21:34.210Z","model":{"id":"b336d883-18f3-4e77-bb20-bd3e62757e78","companyId":"af791bbb-c3b4-4628-bfe7-8404c754dd09","modelName":"B-TEMIA Keeogo","slug":"btemia-keeogo","description":"Powered (motorized bilateral-knee) wearable exoskeleton for mobility assistance - walking, stairs, sit-to-stand, squatting - for people with stroke, MS, SCI or degenerative conditions. ~5.4 kg with hip battery. CE-marked; sold in Canada, Europe and Asia.","formFactor":"exoskeleton","industryVertical":null,"environment":null,"maturityStage":"commercial","lifecycleState":"active","supersededByModelId":null,"specs":{"use":"medical / personal mobility","control":"AI dermoskeleton (rigid+flexible hybrid)","powered":"yes (motorized knees)","regulatory":"CE-marked","body_region":"bilateral legs (hips/knees)","availability":"commercial"},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://b-temia.com/keeogo/","title":"B-TEMIA Keeogo","sourceName":"B-TEMIA (primary)"},{"url":"https://www.btemia.com/en/keeogo","title":"Keeogo Dermoskeleton","sourceName":"B-Temia"},{"url":"https://b-temia.com/keeogo/","title":"B-TEMIA Keeogo (re-verified primary source)"}],"aliases":["Keeogo","Keeogo+"],"collisionRisk":"low","reviewNote":"reverified 2026-06-09 (Kimi-incident remediation): re-sourced against a current resolving authoritative source (manufacturer/regulator/reputable); relevance confirmed.","manufacturerTermForTeleop":null,"keyFacts":[{"label":"Robot","value":"Keeogo is a motorized bilateral-knee dermoskeleton for mobility assistance."},{"label":"Technology","value":"Dermoskeleton platform"},{"label":"Country","value":"Canada"},{"label":"Product","value":"Keeogo powered walking assist exoskeleton"},{"label":"Partner","value":"Wistron (manufacturing/commercialization in Asia)"}],"createdAt":"2026-06-06T02:05:06.745Z","updatedAt":"2026-07-08T20:01:21.068Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"af791bbb-c3b4-4628-bfe7-8404c754dd09","name":"B-TEMIA","slug":"b-temia","description":"Canadian bio-robotics company developing Dermoskeleton™ technology for human mobility augmentation. Its flagship product [Keeogo](/models/btemia-keeogo) is a powered lower-limb exoskeleton that provides motorized knee assistance for stroke patients and individuals with mobility impairments in rehabilitation settings. B-TEMIA received FDA 510(k) clearance for Keeogo in September 2020 and was acquired by Wistron Medical Tech Holding Company in 2025 through a court-approved stalking horse agreement following insolvency proceedings","status":"private","founded":2010,"hq":"Saint-Augustin-de-Desmaures, Quebec, Canada","hqLat":46.8137431,"hqLng":-71.2084061,"hqGeocodedAt":"2026-08-05T14:21:03.778Z","hqAddress":null,"hqPrecision":null,"website":"https://www.b-temia.com","fundingTotal":null,"type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":54,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://b-temia.com/keeogo/","title":"B-TEMIA","sourceName":"B-TEMIA (primary)"},{"url":"https://b-temia.com/","title":"B-TEMIA (official)","sourceName":"B-TEMIA (primary)"}],"keyFacts":[{"label":"CEO","value":"David Quitman (current); Stéphane Bédard (founder, former CEO until Sep 2023)"},{"label":"HQ","value":"Saint-Augustin-de-Desmaures, Quebec, Canada"},{"label":"Founded","value":"2010"},{"label":"Product","value":"Keeogo — powered Dermoskeleton exoskeleton for human mobility augmentation"},{"label":"FDA Clearance","value":"510(k) clearance for Keeogo (K201539), September 2020"},{"label":"Funding","value":"~$11M total raised (company-reported via PitchBook); investors include Canada Economic Development for Quebec Regions and Epic Capital Management"},{"label":"Acquisition","value":"Acquired by Wistron Medical Tech Holding Company (Taiwan) in 2025 via stalking horse agreement following B-TEMIA insolvency proceedings (Dec 2024)"},{"label":"Partnership","value":"DIH Holding US (NASDAQ:DHAI) — exclusive rights to market and sell Keeogo in Canada, US, and Mexico (May 2024)"},{"label":"Taiwan expansion","value":"B-Temia Asia obtained TFDA product license for commercial access to Taiwan"}],"aliases":["B-TEMIA Inc"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-06T02:05:05.191Z","updatedAt":"2026-08-21T22:28:38.469Z"}},"version":null,"location":{"id":"ee320ac7-3d14-4a80-bd64-336f2e601f9d","name":"Montreal","slug":"montreal-canada","kind":"city","parentLocationId":"615dd675-0877-4ad8-8a92-a98e6bda9f21","region":"North America","lat":45.5017,"lng":-73.5673,"reviewStatus":"reverified","aliases":["montreal-quebec-canada","Montreal, Canada"],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-06-07T22:54:24.547Z","updatedAt":"2026-08-10T23:43:12.888Z"},"operator":{"id":"af791bbb-c3b4-4628-bfe7-8404c754dd09","name":"B-TEMIA","slug":"b-temia","description":"Canadian bio-robotics company developing Dermoskeleton™ technology for human mobility augmentation. Its flagship product [Keeogo](/models/btemia-keeogo) is a powered lower-limb exoskeleton that provides motorized knee assistance for stroke patients and individuals with mobility impairments in rehabilitation settings. B-TEMIA received FDA 510(k) clearance for Keeogo in September 2020 and was acquired by Wistron Medical Tech Holding Company in 2025 through a court-approved stalking horse agreement following insolvency proceedings","status":"private","founded":2010,"hq":"Saint-Augustin-de-Desmaures, Quebec, Canada","hqLat":46.8137431,"hqLng":-71.2084061,"hqGeocodedAt":"2026-08-05T14:21:03.778Z","hqAddress":null,"hqPrecision":null,"website":"https://www.b-temia.com","fundingTotal":null,"type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":54,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://b-temia.com/keeogo/","title":"B-TEMIA","sourceName":"B-TEMIA (primary)"},{"url":"https://b-temia.com/","title":"B-TEMIA (official)","sourceName":"B-TEMIA (primary)"}],"keyFacts":[{"label":"CEO","value":"David Quitman (current); Stéphane Bédard (founder, former CEO until Sep 2023)"},{"label":"HQ","value":"Saint-Augustin-de-Desmaures, Quebec, Canada"},{"label":"Founded","value":"2010"},{"label":"Product","value":"Keeogo — powered Dermoskeleton exoskeleton for human mobility augmentation"},{"label":"FDA Clearance","value":"510(k) clearance for Keeogo (K201539), September 2020"},{"label":"Funding","value":"~$11M total raised (company-reported via PitchBook); investors include Canada Economic Development for Quebec Regions and Epic Capital Management"},{"label":"Acquisition","value":"Acquired by Wistron Medical Tech Holding Company (Taiwan) in 2025 via stalking horse agreement following B-TEMIA insolvency proceedings (Dec 2024)"},{"label":"Partnership","value":"DIH Holding US (NASDAQ:DHAI) — exclusive rights to market and sell Keeogo in Canada, US, and Mexico (May 2024)"},{"label":"Taiwan expansion","value":"B-Temia Asia obtained TFDA product license for commercial access to Taiwan"}],"aliases":["B-TEMIA Inc"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-06T02:05:05.191Z","updatedAt":"2026-08-21T22:28:38.469Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/btemia-keeogo-canada-clinical","url":"https://registry.deploy.report/deployments/btemia-keeogo-canada-clinical","name":"B-TEMIA Keeogo at Montreal","identifier":"221614f8-e4a5-4445-a1b6-bbfd4f93ba3f","startDate":"2024-06-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/montreal-canada","name":"Montreal"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/b-temia","name":"B-TEMIA"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/btemia-keeogo","name":"B-TEMIA Keeogo"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":"commercial","lifecycle_state":"active","architectural_position":{"cohort":"exoskeleton","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":[]}}}